Absent T Lymphocytes

Search Trials
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Status:
Completed
Last Changed:
Apr 2, 2014
First Changed:
Nov 3, 2010
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
paliferminflow cytometrylaboratory biomarker analysispharmacological study
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Status:
Completed
Last Changed:
Nov 7, 2014
First Changed:
Jul 8, 2010
Disease(s):
Adult Grade III Lymphomatoid Granulomatosis
Intervention(s):
gamma-secretase/Notch signalling pathway inhibitor RO4929097capecitabinelaboratory biomarker analysis
BCX-1777 in Treating Patients With Refractory Cancer
Status:
Completed
Last Changed:
May 30, 2013
First Changed:
Dec 11, 2003
Disease(s):
Cancer
Intervention(s):
forodesine hydrochloride
Regulation of Mucosal Immune Response to Systemic MenB Vaccine
Status:
Completed
Last Changed:
Nov 15, 2016
First Changed:
Oct 17, 2008
Disease(s):
Meningococcal Infections
Intervention(s):
NZ MenB OMV vaccine (NZ98/254)
BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
Status:
No longer available
Last Changed:
Oct 5, 2020
First Changed:
Aug 21, 2018
Disease(s):
Hurler Syndrome
Intervention(s):
rivogenlecleucelrimiducid

Connect. Empower. Inspire.